Singlomics - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Singlomics

company

Summary
Funding Rounds
Investors

About

Singlomics uses single-cell sequencing technology for antibody drug discovery.

Highlights

Total Funding Amount

Details

Last Funding Type: Series B
Last Funding Money Raised: ¥300M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2020
Operating Status: Active

Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥300M

Singlomics has raised a total of ¥300M in funding over 2 rounds. Their latest funding was raised on Feb 2, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Feb 2, 2022	Series B	¥300M	3	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

3

Singlomics is funded by 3 investors. JIANYI CAPITAL and Witruth Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
JIANYI CAPITAL	—	Series B
Witruth Capital	—	Series B
Ruihua Venture Capital	—	Series B